中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
13期
157-158
,共2页
丙戊酸钠缓释片%卡马西平%脑炎后癫痫
丙戊痠鈉緩釋片%卡馬西平%腦炎後癲癇
병무산납완석편%잡마서평%뇌염후전간
Sodium valproate%Carbamazepine%Post-encephalitic epilepsy
目的:观察卡马西平与丙戊酸钠缓释片治疗脑炎后癫痫的临床疗效,并对比两者的治疗效果。方法将2013~2014年在我院接受治疗的90例脑炎后癫痫患者作为研究对象,将其随机分为A组和B组,每组45例。给予A组患者卡马西平进行治疗,给予B组患者丙戊酸钠缓释片进行治疗,观察并对比两组患者的治疗效果以及不良反应情况。结果两组患者的治疗总有效率的差异不具有统计学意义(P>0.05)。两组患者的不良反应发生率的差异不具有统计学意义(P>0.05)。结论卡马西平与丙戊酸钠缓释片治疗脑炎后癫痫的临床疗效相当。
目的:觀察卡馬西平與丙戊痠鈉緩釋片治療腦炎後癲癇的臨床療效,併對比兩者的治療效果。方法將2013~2014年在我院接受治療的90例腦炎後癲癇患者作為研究對象,將其隨機分為A組和B組,每組45例。給予A組患者卡馬西平進行治療,給予B組患者丙戊痠鈉緩釋片進行治療,觀察併對比兩組患者的治療效果以及不良反應情況。結果兩組患者的治療總有效率的差異不具有統計學意義(P>0.05)。兩組患者的不良反應髮生率的差異不具有統計學意義(P>0.05)。結論卡馬西平與丙戊痠鈉緩釋片治療腦炎後癲癇的臨床療效相噹。
목적:관찰잡마서평여병무산납완석편치료뇌염후전간적림상료효,병대비량자적치료효과。방법장2013~2014년재아원접수치료적90례뇌염후전간환자작위연구대상,장기수궤분위A조화B조,매조45례。급여A조환자잡마서평진행치료,급여B조환자병무산납완석편진행치료,관찰병대비량조환자적치료효과이급불량반응정황。결과량조환자적치료총유효솔적차이불구유통계학의의(P>0.05)。량조환자적불량반응발생솔적차이불구유통계학의의(P>0.05)。결론잡마서평여병무산납완석편치료뇌염후전간적림상료효상당。
Objective To observe and compare the clinical efficacy of carbamazepine and sodium valproate in the treatment of post-encephalitic epilepsy. Methods 90 cases of post-encephalitic epilepsy patients were treated in our hospital from 2013 to 2014. The patients were randomly divided into group A and group B,45 cases in each group. The patients of A group were treated by carbamazepine. The patients of B group were treated by sodium valproate. Therapeutic effects and adverse reactions were observed and compared. Results The two groups have no significant difference in the total efficiency(P>0.05),the difference was not statistical y significant. The rate of adverse reaction has no significant difference in two groups on the(P>0.05),the difference was not statistical y significant. Conclusion Carbamazepine and sodium valproate have the same effect in the treatment of post-encephalitic epilepsy.